Discovery of Medicines | Get Science
“I like to think about drug discovery as solving a very complex jigsaw puzzle with many thousands of pieces,” says Mark Noe, Vice President of Discovery Sciences in Pfizer’s Groton, CT Research and De...
Introduction to Intellectual Property and Entrepreneurship for Biotherapeutic Scientists
Workshop Overview: The Clinical Translation Education Group will be hosting a one-day workshop on intellectual property (IP) and entrepreneurship. It will be aimed at highly-qualified personnel (HQP), with the objective of introducing key topics related to IP and entrepreneurship within the context of biotherapeutic technologies for scientists in academia. Objectives: Understand, at a high level, what IP is. Understand how to conduct a patent search. Understand how to navigate the IP process with your university's Tech Transfer Office (TTO). Learn the fundamental aspects of entrepreneurship in the context of a biotherapeutic discovery. Topics Covered: IP 101 Conducting patent searches Working with your university’s TTO Keynote on IP How do I finance the development of my discovery? Introduction to business plans and term sheets Meet the experts in IP and entrepreneurship fields Agenda and Speakers: The agenda and speakers for the workshop are being finalized now. Please stay tuned for more information so...
NEW TRENDS IN CLINICAL TRIALS: How Data Capabilities Will Transform Clinical Trials
Please join us for a session that will focus on how evolving data mining capabilities and advanced technologies, such as artificial intelligence and genomics, will impact clinical trials and healthcare innovation. This high-profile event highlights opportunities for the industry to innovate clinical trials through these technologies and to promote Ontario and Quebec’s joint capabilities for conducting clinical trials. Dr. Molly Shoichet PhD, O.C., O. Ont., NAEOntario’s first Chief Scientist and a world-leading expert in the study of polymers for drug delivery and in tissue regeneration, with a focus on spinal cord injuries, strokes and blindness. Rémi Quirion, OC, PhD, CQ, FRSCQuébec’s first Chief Scientist and chair on the boards of directors for the three Fonds de recherche du Québec andadvises the Minister of Economy, Science and Innovation on research and scientific development issues. Michael Duong, PhDDirector for Evidence Generation in Medical Affairs for Hoffmann-La Roche Limited, managing a team r...
Changing the scope of clinical trials in Canada - Biotechnology Focus
It would be too easy to say that last week’s CTO 2018 Clinical Trials Conference was an immense success – but it was. A sold-out event with 400 people speaks for itself. It was held in Toronto at the Sheraton Centre Hotel over two days chalked full of intrinsic speakers and panels discussing clinical research, clinical trials, and patient engagement.
Canada Country Partnership Announcement - SingularityU Canada
It's Official! SingularityU Canada is the Newest SingularityU Country Partner SingularityU Canada will create a platform that brings together uncommon partners to have strategic conversations and collaborate on our collective future TORONTO, CANADA / MOUNTAIN VIEW, CALIF., USA - February 28, 2018 - Singularity University (SU), the global learning and innovation enterprise that educates individuals and organizations on accelerating technological change, has announced SingularityU Canada as the newest SingularityU country partner.
Health System Innovation
Join us in a knowledge thought-leader event on Health System Innovation - in Brampton and beyond. Moderated by Ms. Giselle Commissiong, Partner EY Life Sciences, the expert panel will discuss and share health system innovations.
Dawn P Richards: The patient as a person – The BMJ
We need to recognise individuals as more than simply a patient Wife. Scientist. Daughter. Aunt. Friend. Entrepreneur. Volunteer. Advocate. Consultant. Traveller. Person who lives with rheumatoid arth...
J&J Innovation Podcast: 012 - Changing the Way We Think About CNS Drug Development
On this episode of the J&J Innovation Podcast, Bill Martin, CSO of Blackthorn Therapeutics, talks about the work they are doing to change the way we think about drug development, specifically as it pertains to treating brain disorders.
LSO - LSO Annual Awards Presentation -
MEMBER LOGIN Email: Password: Forgot Password? | Become a Member I am part of a Corporate Membership LSO Annual Awards Presentation Wednesday, February 28, 2018 LSO 2018 Celebra...